NSCLC, Stereotactic body radiotherapy, SBRT, Hypofractionated, Radiotherapy
Showing 1 - 25 of >10,000
NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- Stereotactic body radiotherapy
- +2 more
- (no location specified)
Jul 5, 2022
Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Houston
Active, not recruiting
- Malignant Solid Neoplasm
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)
Not yet recruiting
- Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
- tereotactic body radiotherapy
- (no location specified)
Dec 1, 2023
NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body
Not yet recruiting
- NSCLC
- +3 more
- Low Dose Radiotherapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Nov 11, 2022
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Stereotactic Body Radiotherapy for Medically Inoperable
Recruiting
- Kidney Neoplasm
- +2 more
- SBRT
-
Terrassa, Barcelona, SpainConsorci Sanitari de Terrassa
Apr 5, 2023
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Lung Cancer, Radiotherapy, Stereotactic Body Radiotherapy Trial in Peking (SBRT)
Active, not recruiting
- Lung Cancer
- +3 more
- SBRT
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Mar 26, 2023
Lung Tumor Malignant Trial in Milano (SBRT, Surgery)
Not yet recruiting
- Lung Neoplasm Malignant
- SBRT
- Surgery
-
Milano, MI, ItalyIstituto Europeo di Oncologia IRCCS
Jul 26, 2023
Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate SBRT (stereotactic body radiation therapy) with focal boost
-
Madrid, SpainLa Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023
NSCLC, NSCLC Stage IV Trial in Madison (Durvalumab, Tremelimumab, Stereotactic Body Radiotherapy)
Active, not recruiting
- Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer Stage IV
- Durvalumab
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 21, 2022
Spinal Tumors Trial in Houston (Stereotactic Body Radiotherapy)
Active, not recruiting
- Spinal Neoplasms
- Stereotactic Body Radiotherapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
NSCLC, Stereotactic Body Radiotherapy, Comprehensive Geriatric Assessment Trial in Denmark (Comprehensive Geriatric Assessment)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- Comprehensive Geriatric Assessment
-
Aarhus, Aarhus N, Denmark
- +3 more
Jun 22, 2023
Prostate Cancer Trial in Sutton (SBRT)
Recruiting
- Prostate Cancer
- SBRT
-
Sutton, Surrey, United KingdomThe Royal Marsden Nhs Foundation Trust
Jun 9, 2022
Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)
Not yet recruiting
- Neoplasms
- Secondary Malignant Neoplasm
- SBRT + LDRT
- SBRT alone
- (no location specified)
Nov 15, 2022
Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body
Recruiting
- Prostate Cancer
- Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
- Stereotactic Body Radiation Therapy to the prostate
-
Québec, CanadaCentre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023
Prostate Cancer Trial in Toronto (stereotactic body radiotherapy (SBRT))
Recruiting
- Prostate Cancer
- stereotactic body radiotherapy (SBRT)
-
Toronto, Onatrio, CanadaSunnybrook Cancer center
Oct 25, 2022
Prostate, Lung, Melanoma and Breast Cancer Patients Following
Recruiting
- Prostate Cancer
- +3 more
- SBRT
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Sarcoma, Thoracic Cancer, Abdominal Cancer Trial in Saint Louis (Stereotactic body radiotherapy, Research blood draw)
Active, not recruiting
- Sarcoma
- +3 more
- Stereotactic body radiotherapy
- Research blood draw
-
Saint Louis, MissouriWashington University School of Medicine
Oct 17, 2022
Early Lung Cancer, Stereotactic Body Radiotherapy Trial in Peking (SBRT)
Not yet recruiting
- Early Lung Cancer
- Stereotactic Body Radiotherapy
- SBRT
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Mar 26, 2023
Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)
Recruiting
- Pancreatic Cancer
- LDR
- +2 more
-
Modena, MO, ItalyAzienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022
Spinal Metastases Trial in Shanghai (Intraoperative radiotherapy (IORT), Stereotactic body radiotherapy (SBRT))
Not yet recruiting
- Spinal Metastases
- Intraoperative radiotherapy (IORT)
- Stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Oct 20, 2023
Proton-Based Stereotactic Ablative Body Radiotherapy for
Active, not recruiting
- Prostate Cancer
- Proton beam
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 26, 2022
Prostate Cancer Trial in New York (177Lu-PSMA-617, Stereotactic Body Radiotherapy (SBRT))
Active, not recruiting
- Prostate Cancer
- 177Lu-PSMA-617
- Stereotactic Body Radiotherapy (SBRT)
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 17, 2022